Julie Trautwein
Overview
Explore the profile of Julie Trautwein including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
1530
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Miyamoto D, Zheng Y, Wittner B, Lee R, Zhu H, Broderick K, et al.
Science
. 2015 Sep;
349(6254):1351-6.
PMID: 26383955
Prostate cancer is initially responsive to androgen deprivation, but the effectiveness of androgen receptor (AR) inhibitors in recurrent disease is variable. Biopsy of bone metastases is challenging; hence, sampling circulating...
2.
Ting D, Wittner B, Ligorio M, Vincent Jordan N, Shah A, Miyamoto D, et al.
Cell Rep
. 2014 Sep;
8(6):1905-1918.
PMID: 25242334
Circulating tumor cells (CTCs) are shed from primary tumors into the bloodstream, mediating the hematogenous spread of cancer to distant organs. To define their composition, we compared genome-wide expression profiles...
3.
Karabacak N, Spuhler P, Fachin F, Lim E, Pai V, Ozkumur E, et al.
Nat Protoc
. 2014 Mar;
9(3):694-710.
PMID: 24577360
The ability to isolate and analyze rare circulating tumor cells (CTCs) has the potential to further our understanding of cancer metastasis and enhance the care of cancer patients. In this...
4.
Ozkumur E, Shah A, Ciciliano J, Emmink B, Miyamoto D, Brachtel E, et al.
Sci Transl Med
. 2013 Apr;
5(179):179ra47.
PMID: 23552373
Circulating tumor cells (CTCs) are shed into the bloodstream from primary and metastatic tumor deposits. Their isolation and analysis hold great promise for the early detection of invasive cancer and...
5.
Miyamoto D, Lee R, Stott S, Ting D, Wittner B, Ulman M, et al.
Cancer Discov
. 2012 Oct;
2(11):995-1003.
PMID: 23093251
Unlabelled: Androgen deprivation therapy (ADT) is initially effective in treating metastatic prostate cancer, and secondary hormonal therapies are being tested to suppress androgen receptor (AR) reactivation in castration-resistant prostate cancer...